Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
임상 실습의 최근 발전: COVID-19 대유행 중 염증성 장 질환 관리
Review
[키워드] acquisition
adverse outcome
adverse outcomes
antibody
booster dose
bowel
Breakthrough infection
breakthrough infections
Cancer
cancers
Corticosteroid
Corticosteroids
COVID-19
COVID-19 in patient
COVID-19 pandemic
Crohn's disease
de novo
decrease
develop
diagnoses
disease course
dose
Evidence
Future
General population
Guidance
hospitalisation
hospitalisations
Humoral response
humoral responses
IBD
immune
immune response
immunosuppressive therapies
immunosuppressive therapy
increased risk
Inflammatory
Inflammatory bowel disease
management
medication
medications
Necrosis
outcome
outcomes
pandemic
Patient
patients
potential risk
primary dose
raised
receive
recent
remained
Research
risk
risk of COVID-19
SARS-CoV-2
SARS-CoV-2 vaccine
SARS-CoV-2 vaccines
TNF
treated
Treatment
ulcerative
ulcerative colitis
Vaccine
vaccine response
Vaccines
[DOI] 10.1136/gutjnl-2021-326784 PMC 바로가기 [Article Type] Review
[DOI] 10.1136/gutjnl-2021-326784 PMC 바로가기 [Article Type] Review